Allas, S., Mohideen, P., Delale, T., Lin, V., Tremel, N., Yeh, M., & Tauber, M. (2019). SAT-100 Trial-in-Progress: ZEPHYR, a Pivotal Phase 2b/3 Randomized, Placebo-Controlled Study of Livoletide, a Novel Unacylated Ghrelin Analog, for the Treatment of Hyperphagia and Food-Related Behaviors in Patients with Prader-Willi Syndrome. J Endocr Soc.

Allas, Soraya, Pharis Mohideen, Thomas Delale, Vivian Lin, Nadege Tremel, Michael Yeh, and Maithe Tauber. "SAT-100 Trial-in-Progress: ZEPHYR, a Pivotal Phase 2b/3 Randomized, Placebo-Controlled Study of Livoletide, a Novel Unacylated Ghrelin Analog, for the Treatment of Hyperphagia and Food-Related Behaviors in Patients With Prader-Willi Syndrome." J Endocr Soc 2019.

Allas, Soraya, et al. "SAT-100 Trial-in-Progress: ZEPHYR, a Pivotal Phase 2b/3 Randomized, Placebo-Controlled Study of Livoletide, a Novel Unacylated Ghrelin Analog, for the Treatment of Hyperphagia and Food-Related Behaviors in Patients With Prader-Willi Syndrome." J Endocr Soc 2019.